The beta 3-adrenoceptor: physiological role and potential therapeutic applications.
Balligand
J L
JL
Unit of Pharmacology and Therapeutics, Université catholique de Louvain, Bruxelles, Belgium. balligand@mint.ucl.ac.be
D017667:Adipocytes / Q000378:metabolism; D058667:Adrenergic beta-3 Receptor Agonists; D058673:Adrenergic beta-3 Receptor Antagonists; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002395:Catecholamines / Q000502:physiology; D006321:Heart / Q000187:drug effects; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000187:drug effects / Q000502:physiology; D022702:Receptors, Adrenergic, beta-3 / Q000502:physiology*
D058667:Adrenergic beta-3 Receptor Agonists; D058673:Adrenergic beta-3 Receptor Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D002317:Cardiovascular Agents; D002395:Catecholamines; D022702:Receptors, Adrenergic, beta-3; D019001:Nitric Oxide Synthase